|
Jul 27
|
Is Viking Therapeutics a Millionaire-Maker Stock?
|
|
Jul 26
|
June PCE inflation print, auto earnings: Morning Brief
|
|
Jul 26
|
Viking’s new dual GLP-1R/GIPR agonist expected to start Phase III trials soon
|
|
Jul 26
|
Eli Lilly loses $120B in value over Viking's GLP-1 progress
|
|
Jul 25
|
Why Weight Loss Drug Developer Stocks Tumbled on Thursday
|
|
Jul 25
|
Viking Therapeutics Unveils Monthly Weight-Loss Shot, Rocking Eli Lilly, Novo Nordisk
|
|
Jul 25
|
Why Viking’s Weight-Loss Drug News Is Weighing on Eli Lilly, Novo Nordisk Stocks
|
|
Jul 25
|
Viking Therapeutics weight-loss drug moves to Phase 3 trial
|
|
Jul 25
|
Viking (VKTX) Q2 Earnings Beat, Stock Up on Pipeline Updates
|
|
Jul 25
|
Viking Stock Jumps After Company Speeds Development Its Weight-Loss Pill
|
|
Jul 25
|
Viking shares jump on plans to speed obesity drug into late-stage testing
|
|
Jul 25
|
Nvidia, Ford, Chipotle, Viking Therapeutics, Tesla: Why These 5 Stocks Are On Investors' Radars Today
|
|
Jul 24
|
Viking Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
|
|
Jul 24
|
The Zacks Analyst Blog Highlights Boston Scientific, Thermo Fisher Scientific, Align Technology and Edwards Lifesciences
|
|
Jul 23
|
Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?
|
|
Jul 2
|
Viking (VKTX) Skyrockets 197% YTD: Is the Stock Worth a Buy?
|
|
Jul 1
|
Viking Therapeutics Stock Is Up by 154% Since January -- Can It Double Again in the Second Half of the Year?
|
|
Jun 30
|
3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics
|
|
Jun 28
|
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
|
|
Jun 27
|
What Makes Viking Therapeutics, Inc. (VKTX) One of the Best Healthcare Stocks to Buy Under $50?
|